These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16220064)

  • 61. Clinical efficacy of olmesartan medoxomil.
    Brunner HR; Laeis P
    J Hypertens Suppl; 2003 May; 21(2):S43-6. PubMed ID: 12929907
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Can the pharmacokinetic characteristics of olmesartan medoxomil contribute to the improvement of blood pressure control?
    Wehling M
    Clin Ther; 2004; 26 Suppl A():A21-7. PubMed ID: 15291376
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension.
    Barrios V; Escobar C
    Expert Opin Pharmacother; 2008 Jan; 9(1):129-36. PubMed ID: 18076344
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Olmesartan medoxomil.
    Warner GT; Jarvis B
    Drugs; 2002; 62(9):1345-53; discussion 1354-6. PubMed ID: 12076183
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide.
    Rump LC; Sellin L
    Expert Opin Pharmacother; 2010 Sep; 11(13):2231-42. PubMed ID: 20707758
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Review of Olmesartan-based Therapy in Targeting Effective Blood Pressure Control and Achieving Blood Pressure Goals.
    Tiwaskar M; Mehta KK; Kasture P
    J Assoc Physicians India; 2024 Mar; 72(3):75-78. PubMed ID: 38736121
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Medication of the month. Olmesartan medoxomil hydroclorothiazide (Olmetec Plus or Belsar Plus].
    Lancellotti P
    Rev Med Liege; 2007 Mar; 62(3):175-9. PubMed ID: 17511387
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Olmesartan medoxomil: recent clinical and experimental acquisitions.
    Destro M; Preti P; D'Ospina A; Christian Achiri NN; Ricci AR; Cagnoni F
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1149-57. PubMed ID: 19689219
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Multicenter trial of olmesartan. Main results].
    Ageev FT; Svirida ON
    Ter Arkh; 2011; 83(9):54-60. PubMed ID: 22145389
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies.
    Zannad F; Fay R
    Fundam Clin Pharmacol; 2007 Apr; 21(2):181-90. PubMed ID: 17391291
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of Hypertension Using Olmesartan Alone or in Combination.
    Zhang X; Zhang H; Ma Y; Che W; Hamblin MR
    Cardiol Ther; 2017 Jun; 6(1):13-32. PubMed ID: 28258390
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers.
    Imaizumi S; Miura S; Yahiro E; Uehara Y; Komuro I; Saku K
    Curr Pharm Des; 2013; 19(17):3002-8. PubMed ID: 23176212
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A review of the structural and functional features of olmesartan medoxomil, an angiotensin receptor blocker.
    Mire DE; Silfani TN; Pugsley MK
    J Cardiovasc Pharmacol; 2005 Nov; 46(5):585-93. PubMed ID: 16220064
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antagonizing the angiotensin II subtype 1 receptor: a focus on olmesartan medoxomil.
    Nussberger J; Koike H
    Clin Ther; 2004; 26 Suppl A():A12-20. PubMed ID: 15291375
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Olmesartan medoxomil: an angiotensin II-receptor blocker.
    Brousil JA; Burke JM
    Clin Ther; 2003 Apr; 25(4):1041-55. PubMed ID: 12809956
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of olmesartan medoxomil in the management of hypertension.
    Unger T; McInnes GT; Neutel JM; Böhm M
    Drugs; 2004; 64(24):2731-9. PubMed ID: 15563246
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Olmesartan medoxomil: the seventh angiotensin receptor antagonist.
    Gardner SF; Franks AM
    Ann Pharmacother; 2003 Jan; 37(1):99-105. PubMed ID: 12503943
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Olmesartan medoxomil: in children and adolescents with hypertension.
    Muir VJ; Keating GM
    Drugs; 2010 Dec; 70(18):2439-47. PubMed ID: 21142262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 4.